Stock Screener App

Frei -

Installieren

8.32

2.34% 0.19

after-market

Handel nachbörslich: 8.32

Iteos Therapeutics Inc (ITOS)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Iteos Therapeutics Inc-Aktie (ITOS)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	12.60
Operating Expenses	17.65% 47.23	40.15	43.28	42.62	37.52
Depreciation and Amortization	33.92% 0.304	0.227	0.20	0.20	0.222
Operating Income/Loss	17.65% -47.23	-40.15	-43.28	-42.62	-24.93
Income/Loss From Continuing Operations Before Tax	27.72% -36.00	-28.19	-33.42	-33.07	-14.35
Income Tax Expense/Benefit	6.31% 2.214	2.363	-1.181	1.232	1.199
Income/Loss From Continuing Operations After Tax	25.09% -38.22	-30.55	-32.24	-34.30	-15.55
Net Income/Loss	25.09% -38.22	-30.55	-32.24	-34.30	-15.55
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	496.00K% 35.84	0.00723	35.78	35.77	35.72
Diluted Average Shares	496.00K% 35.84	0.00723	35.78	35.77	35.72
Basic Earnings Per Share	25.88% -1.07	-0.85	-0.90	-0.96	-0.44
Diluted Earnings Per Share	25.88% -1.07	-0.85	-0.90	-0.96	-0.44
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

INCY

$71.72

1.89%

SMMT

$19.00

3.15%

MRNA

$41.11

7.48%

UTHR

$372.89

1.51%

BGNE

$190.51

2.08%

BNTX

$113.13

4.53%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters